Login
$ORKA
$99.24 -$6.11 (5.8%) Live

$ORKA SEC Filings

Filed On Filing
16 Nov 2026 Form 4: Goncalves Joana, Chief Medical Officer

Received 7,000 shares by exercise or conversion ($51.2K) · Sold 7,000 shares ($707K)

16 Nov 2026 SCHEDULE 13G
16 Nov 2026 SCHEDULE 13G/A
13 Nov 2026 Form 4: Agarwal Arjun, Senior Vice President, Finance

Received 10,000 shares by exercise or conversion ($157K) · Sold 10,000 shares ($1.05M)

13 Nov 2026 Form 4: Ball Kristine M, Director

Received 18,000 shares by exercise or conversion ($123K) · Sold 18,000 shares ($1.89M)

12 Nov 2026 144
12 Nov 2026 144
09 Nov 2026 QUARTERLY REPORT
02 Nov 2026 Form 4: Klein Lawrence Otto, Director

Received 25,000 shares by exercise or conversion ($195K) · Sold 25,000 shares ($2.39M)

02 Nov 2026 144
26 Oct 2026 8-K: Regulation FD Disclosure; Other Events

©2026 Oruka Therapeutics ©2026 ORUKA THERAPEUTICS EVERLAST - B Interim Data ORKA - 001 Phase 2b trial in psoriasis October 26, 2026

20 Oct 2026 Form 4: Quinlan Paul T, General Counsel

Received 9,000 shares by exercise or conversion ($70.2K) · Sold 9,000 shares ($707K)

15 Oct 2026 Form 4: Goncalves Joana, Chief Medical Officer

Received 7,000 shares by exercise or conversion ($51.2K) · Sold 7,000 shares ($524K)

15 Oct 2026 144
13 Oct 2026 Form 4: Agarwal Arjun, Senior Vice President, Finance

Received 9,999 shares by exercise or conversion ($157K) · Sold 9,999 shares ($806K)

13 Oct 2026 144
02 Oct 2026 Form 4: Klein Lawrence Otto, Director

Received 25,000 shares by exercise or conversion ($195K) · Sold 25,000 shares ($2.09M)

01 Oct 2026 144
21 Sep 2026 Form 4: Agarwal Arjun, Senior Vice President, Finance

Sold 533 shares ($51K)

21 Sep 2026 Form 4: Quinlan Paul T, General Counsel

Received 10,000 shares by exercise or conversion ($78K) · Sold 10,000 shares ($936K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support